DavidGPfisterMD

Professor of Medicine, Cornell University-Weill Medical College

Overview of Dr. Pfister

Dr. David Pfister is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 35 years. Dr. Pfister accepts several types of health insurance, listed below. He is one of 464 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 100 publications and over 500 citings.

Office
Memorial Sloan Kettering Cancer Center New York
1275 York Avenue
New York, NY 10021
Book by Phone+1(904) 729-4612
Is this information wrong?

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1987 - 1989
Yale-New Haven Medical CenterResidency, Internal Medicine, 1985 - 1987
University of Pennsylvania Health SystemResidency, Internal Medicine, 1982 - 1985
Perelman School of Medicine at the University of PennsylvaniaClass of 1982

Certifications & Licensure

NY State Medical License 1987 - 2026
NJ State Medical License 2019 - 2025
PA State Medical License 1984 - 1988
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
Top Doctors: New York Metro Area Castle Connolly, 2005-2014
New York Magazine: Top Doctors Castle Connolly, 2005-2008, 2010-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Fellow (FASCO) American Society of Clinical Oncologists, 2008
Join now to see all

Clinical Trials

Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781] Start of enrollment: 1998 Jul 01
Terminated
Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer Start of enrollment: 1998 Jul 01
Completed
Phase 2
SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck Start of enrollment: 2000 Dec 01
Completed
Phase 2
Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer Start of enrollment: 2003 Nov 01
Completed
Phase 3
Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine Start of enrollment: 2004 Oct 01
Completed
Phase 2
A Randomized Study of Sulindac in Oral Premalignant Lesions Start of enrollment: 2006 Feb 23
Completed
Not Applicable
Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors Start of enrollment: 2006 Nov 01
Completed
Phase 1
Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer Start of enrollment: 2006 Oct 01
Completed
Phase 2
Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Start of enrollment: 2007 Jul 01
Completed
Phase 2
A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC) Start of enrollment: 2006 Sep 01
Completed
Phase 2
Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy Start of enrollment: 2008 Aug 01
Completed
Phase 2
Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) Start of enrollment: 2009 Nov 01
Completed
Phase 1, Phase 2
Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma Start of enrollment: 2010 Dec 28
Completed
Not Applicable
Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC) Start of enrollment: 2014 Oct 30
Completed
Phase 1
Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers Start of enrollment: 2020 Jun 02
Recruiting
Phase 2
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer Start of enrollment: 2020 Sep 02
Active, not recruiting
Phase 2
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer Start of enrollment: 2021 Jan 20
Recruiting
Phase 1
Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer Start of enrollment: 2020 Jan 20
Recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Hypoxia-Directed Treatment of Human Papillomavirus-Related Oropharyngeal Carcinoma.
Lee, N., Sherman, E., Schöder, H., Wray, R., Boyle, J., Singh, B., Grkovski, M., Paudyal, R., Cunningham, L., Zhang, Z., Hatzoglou, V., Katabi, N., Diplas, B., Han, J....> ;Journal of Clinical Oncology. 2024 Mar 10
A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).
Alan L Ho, Nathan R Foster, Shyamprasad Deraje Vasudeva, Nora Katabi, Cristina R Antonescu, Gary P Frenette, David G Pfister, Charles Erlichman, Schwartz, G.> ;Cancer. 2024 Mar 1
A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Albiruni R Abdul Razak, Hung-Ming Wang, Jang-Yang Chang, Myung-Ju Ahn, Pamela Munster, George Blumenschein Jr, Benjamin Solomon, Darren Wan-Teck Lim, Ruey-Long Hong, D...> ;Targeted Oncology. 2023 Nov 1
Virtual Tumor Board to Foster Interinstitutional Head and Neck Cancer Subspecialty Care.
Tony K W Hung, Daphna Y Gelblum, Clinton A Kuwada, Akshay V Patel, Andrew Salner, David G Pfister, Jennifer R Cracchiolo> ;JAMA Otolaryngology-- Head & Neck Surgery. 2023 Dec 1
5 citations
International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors.
Kuan, E., Wang, E., Adappa, N., Beswick, D., London, N., Su, S., Wang, M., Abuzeid, W., Alexiev, B., Alt, J., Antognoni, P., Alonso-Basanta, M., Batra, P., Bhayani, M....> ;International Forum of Allergy & Rhinology. 2024 Feb 1
7 citations
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.
Joris L Vos, Bharat Burman, Swati Jain, Conall W R Fitzgerald, Eric J Sherman, Lara A Dunn, James V Fetten, Loren S Michel, Anuja Kriplani, Kenneth K Ng, Juliana Eng, ...> ;Nature Medicine. 2023 Dec 1
1 citations
Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial.
Nancy Y Lee, Jonathan Harris, John Kim, Adam Garden, James Mechalakos, David G Pfister, Anthony T C Chan, Kenneth Hu, A Dimitrios Colevas, Steven Frank, George Shenoud...> ;JAMA Network Open. 2023 Jun 1
Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity.
Yao Yu, Heiko Schöder, Kaveh Zakeri, Linda Chen, Jung Julie Kang, Sean Matthew McBride, C Jillian Tsai, Daphna Y Gelblum, Jay O Boyle, Jennifer R Cracchiolo, Marc A Co...> ;Oral Oncology. 2023 Jun 1
6 citations
Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma.
Anna Lee, Robbie Woods, Amgad Mahfouz, Sarin Kitpanit, Olivia Cartano, Nader Mohamed, Irini Youssef, Kathryn Marqueen, Kevin Sine, Dennis Mah, Brian Neal, Kaveh Zakeri...> ;JAMA Network Open. 2023 Jan 3
8 citations
Biomarkers predictive of response to pembrolizumab in head and neck cancer.
David G Pfister, Robert I Haddad, Francis P Worden, Jared Weiss, Ranee Mehra, Laura Q M Chow, Stephen V Liu, Hyunseok Kang, Nabil F Saba, Lori J Wirth, Ammar Sukari, E...> ;Cancer Medicine. 2023 Mar 1
Assessment of Oncology Patient Engagement and Interest in Virtual Mind-Body Programming: Moving Toward Personalization of Virtual Care.
Tony K W Hung, Shelly Latte-Naor, Yuelin Li, Gilad J Kuperman, Christina Seluzicki, Eva Pendleton, David G Pfister, Jun J Mao> ;JCO Oncology Practice. 2023 Feb 1
8 citations
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulate...
Irini Youssef, Jennifer Yoon, Nader Mohamed, Kaveh Zakeri, Robert H Press, Linda Chen, Daphna Y Gelblum, Sean M McBride, Chiaojung Jillian Tsai, Nadeem Riaz, Yao Yu, M...> ;JAMA Network Open. 2022 Nov 1
17 citations
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancer.
Jung Julie Kang, Yao Yu, Linda Chen, Kaveh Zakeri, Daphna Yael Gelblum, Sean Matthew McBride, Nadeem Riaz, C Jillian Tsai, Anuja Kriplani, Tony K W Hung, James V Fette...> ;CA. 2023 Mar 1
2 citations
Comparison of Objective Measures of Trismus and Salivation With Patient-Reported Outcomes Following Treatment for Head and Neck Cancer.
Sallie M Long, Annu Singh, Amy L Tin, Bridget O'Hara, Marc A Cohen, Nancy Lee, David G Pfister, Tony Hung, Richard J Wong, Andrew J Vickers, Cherry L Estilo, Jennifer ...> ;JAMA Otolaryngology-- Head & Neck Surgery. 2022 Aug 1
2 citations
Multidisciplinary Treatment of Non-Spine Bone Metastases: Results of a Modified Delphi Consensus Process.
Erin F Gillespie, Noah J Mathis, Max Vaynrub, Ernesto Santos Martin, Rupesh Kotecha, Joseph Panoff, Andrew L Salner, Alyson F McIntosh, Ranju Gupta, Amitabh Gulati, Di...> ;Clinical and Translational Radiation Oncology. 2022 Jul 1
4 citations
A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image-Guided Stereotactic Body Radiotherapy in the Treatment of Metastatic Anaplastic Thyr...
Nancy Y Lee, Nadeem Riaz, Vanessa Wu, Thomas Brinkman, Chiaojung J Tsai, Wanquing Zhi, James Fetten, Alan Ho, Richard J Wong, Ronald Ghossein, Michael Tuttle, James Fa...> ;Thyroid. 2022 Jul 1
3 citations
Pharmacodynamic and therapeutic pilot studies of single-agent ribavirin in patients with human papillomavirus-related malignancies.
Bharat Burman, Scott B Drutman, Matthew G Fury, Richard J Wong, Nora Katabi, Alan L Ho, David G Pfister> ;Oral Oncology. 2022 May 1
6 citations
Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series A...
Nahomy Ledesma Vicioso, Diana Lin, Daniel R Gomez, Jonathan T Yang, Nancy Y Lee, Andreas Rimner, Yoshiya Yamada, Michael J Zelefsky, Noah S Kalman, Charles E Rutter, R...> ;JCO Oncology Practice. 2022 May 1
224 citations
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.
Jimmy J Caudell, Maura L Gillison, Ellie Maghami, Sharon Spencer, David G Pfister, Douglas Adkins, Andrew C Birkeland, David M Brizel, Paul M Busse, Anthony J Cmelak, ...> ;Journal of the National Comprehensive Cancer Network. 2022 Mar 1
24 citations
Enhancing Radioiodine Incorporation in-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pi...
Vatche Tchekmedyian, Lara Dunn, Eric Sherman, Shrujal S Baxi, Ravinder K Grewal, Steven M Larson, Keith S Pentlow, Sofia Haque, R Michael Tuttle, Mona M Sabra, Stephan...> ;Thyroid. 2022 Mar 1
27 citations
Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Defin...
C Jillian Tsai, Sean M McBride, Nadeem Riaz, Jung J Kang, Daniel J Spielsinger, Todd Waldenberg, Daphna Gelblum, Yao Yu, Linda C Chen, Kaveh Zakeri, Richard J Wong, La...> ;JAMA Oncology. 2022 Mar 1
Enhancing Enrollment of Patients to Radiation Oncology Clinical Trials Across a Multi-Institutional Community-Academic Partnership: An Interrupted Time Series Analysis.
Diana Lin, Daniel R. Gomez, J.T. Yang, Nancy Y. Lee, Andreas Rimner, Yoshiya Yamada, Michael J. Zelefsky, N S Kalman, Charles E. Rutter, Rupesh Kotecha, Minesh P. Meht...> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
Oropharyngeal Cancer Early Outcomes and Challenges During the COVID-19 Pandemic.
J.J. Kang, Y. Wu, Alisa Rybkin, Yao Yu, Li-Tzong Chen, Kaveh Zakeri, Sean McBride, Nadeem Riaz, C.J. Tsai, Daphna Y. Gelblum, R.J. Wong, Eric J. Sherman, David G. Pfis...> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
1 citations
Therapeutic strategies for systemic therapies of human papillomavirus-related oropharyngeal cancer.
Tony K. W. Hung, Alan L. Ho, David G. Pfister> ;Journal of Surgical Oncology. 2021 Nov 1
Long-term Therapeutic and Functional Outcomes With Organ Preservation for T4 Larynx and Hypopharynx Cancers.
Alisa Rybkin, A. Eita, J.J. Kang, M. Fiasconaro, Zhigang Zhang, Kaveh Zakeri, Yao Yu, Li-Tzong Chen, Daphna Y. Gelblum, C.J. Tsai, Nadeem Riaz, Sean McBride, Eric J. S...> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
Join now to see all

Journal Articles

Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers
Steven M Larson, Sofia Haque, Duan Li, R Michael Tuttle, Mona M Sabra, Alan L Ho, Eric J Sherman, Ravinder K Grewal, James A Fagin, David G Pfister, Ronald A Ghossein, The Journal of Clinical Endocrinology and Metabolism

Press Mentions

Jamaica Hospital, Memorial Sloan Kettering Cancer Center Partner to Expand Access to Cancer Care for Queens and Eastern Brooklyn ResidentsJanuary 25th, 2023
Study Examines Cancer-Care Outcomes Among American HospitalsOctober 8th, 2015
Treatment for Cancer Advances in TrialsAugust 1st, 2000

Grant Support

Acupuncture For Shoulder Syndrome After CA SurgeryNational Cancer Institute2004
Acupuncture For Shoulder Syndrome After Cancer SurgeryNational Cancer Institute2003

Professional Memberships

American College of Physicians - ACP
Member
American Society of Clinical Oncology - ASCO
Fellow

Hospital Affiliations

Memorial Sloan Kettering Cancer CenterNew York, New York

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment